Company
NephroDI
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
NephroDI is a clinical stage company developing an oral small molecule drug for genetic (X-Linked) and drug induced (Tolvaptan and Lithium induced) Nephrogenic Diabetes Insipidus (NDI).
Loading relationship preview